RecruitingNot ApplicableNCT07263984

Added Value of Three-dimensional Transvaginal Ultrasound (3D TVUS) and Gel Infusion Sonography (3D GIS) Compared With Magnetic Resonance Imaging (MRI) in the Diagnosis of Patients With Suspicion of a Uterine Septum.

SEPTUM-D Project: Diagnosis in Patients With a Uterine Septum


Sponsor

University Hospital, Ghent

Enrollment

145 participants

Start Date

Oct 27, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to investigate the added value of three-dimensional transvaginal ultrasound (3D TVUS) and gel infusion sonography (3D GIS) for diagnosing a partition in the uterus (uterine septum) in comparison to magnetic resonance imaging (MRI). The main question it aims to answer is: How well do 3D TVUS and 3D GIS detect a uterine septum compared to MRI? Participants will receive 3D TVUS/ 3D GIS and MRI, and will complete questionnaires.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Magnetic Resonance Imaging, Questionnaires, and others for people with uterine septum. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTMagnetic Resonance Imaging

MRI of the pelvis

DIAGNOSTIC_TESTThree-dimensional transvaginal ultrasound

Three-dimensional transvaginal ultrasound

DIAGNOSTIC_TESTThree-dimensional transvaginal Gel Infusion Sonography

Three-dimensional transvaginal Gel Infusion Sonography

OTHERQuestionnaires

Questionnaires


Locations(1)

Ghent University Hospital

Ghent, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07263984


Related Trials